Liveon Biolabs Profile
Key Indicators
- Authorised Capital ₹ 5.50 Cr
as on 17-12-2024
- Paid Up Capital ₹ 4.39 Cr
as on 17-12-2024
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 17.13 Cr
as on 17-12-2024
- Revenue -7.22%
(FY 2022)
- Profit -189.78%
(FY 2022)
- Ebitda -63.41%
(FY 2022)
- Net Worth 18.10%
(FY 2022)
- Total Assets 44.42%
(FY 2022)
About Liveon Biolabs
The Corporate was formerly known as Pioneer Biofarms & Allied Services Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.50 Cr and a paid-up capital of Rs 4.39 Cr.
The company currently has active open charges totaling ₹17.13 Cr.
Gollahalli Basavaraju, Channarayappa Raaju, and Hanakere Swetha serve as directors at the Company.
- CIN/LLPIN
U74900KA2011PTC058005
- Company No.
058005
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Apr 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Tumkur, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Liveon Biolabs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gollahalli Basavaraju  | Director | 16-Mar-2016 | Current |
| Channarayappa Raaju | Director | 03-Nov-2014 | Current |
| Hanakere Swetha | Additional Director | 21-Oct-2022 | Current |
Financial Performance and Corporate Structure Insights of Liveon Biolabs.
Liveon Biolabs Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 7.22% decrease. The company also saw a substantial fall in profitability, with a 189.78% decrease in profit. The company's net worth Soared by an impressive increase of 18.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Liveon Biolabs?
In 2022, Liveon Biolabs had a promoter holding of 85.06% and a public holding of 14.94%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ashraya Engineers & Developers Private LimitedActive 16 years 10 monthsGollahalli Basavaraju and Channarayappa Raaju are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Jan 2017 | ₹3.50 Cr | Open |
Others Creation Date: 10 May 2013 | ₹2.00 M | Open |
State Bank Of India Creation Date: 05 Sep 2012 | ₹13.43 Cr | Open |
How Many Employees Work at Liveon Biolabs?
Liveon Biolabs has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Liveon Biolabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Liveon Biolabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
